Stereotactic Radiotherapy in Oligometastatic Brain Disease: a Randomised Phase III Study Comparing Hypofractionated Stereotactic Radiation Therapy (3*10 Gy) to the Historical Single-dose Radiosurgery (1*20 to 25 Gy) With Medico-economic Evaluation.
Clinical trial NCT05102747 · RECRUITING
Trial details
- NCT number
- NCT05102747
- Sponsor
- Centre Francois Baclesse
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-12
- Primary completion
- 2030-01-01
- Enrollment
- 504
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.